Abstract:BACKGROUNDThe aim of this study was to evaluate the efficacy and safety of empagliflozin as an add-on drug in type 2 diabetes mellitus (T2DM) patients demonstrating inadequate disease control to triple drug treatment of glimepiride, metformin and teneligliptin.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.